Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.5M
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
46M
-
Shares change
-
+3.9M
-
Total reported value, excl. options
-
$2.16B
-
Value change
-
+$195M
-
Put/Call ratio
-
1.23
-
Number of buys
-
83
-
Number of sells
-
-84
-
Price
-
$47.00
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2018
220 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2018.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46M shares
of 79.5M outstanding shares and own 57.93% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (4.46M shares), BlackRock Inc. (3.64M shares), RTW INVESTMENTS, LP (3.28M shares), FMR LLC (2.77M shares), FRANKLIN RESOURCES INC (2.63M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.49M shares), STATE STREET CORP (2.28M shares), BOXER CAPITAL, LLC (2.16M shares), D. E. Shaw & Co., Inc. (1.76M shares), and SCOPIA CAPITAL MANAGEMENT LP (1.62M shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.